osteoporosis%20in%20women
OSTEOPOROSIS IN WOMEN
Osteoporosis is a progressive, systemic, skeletal disease characterized by decreased bone mass and microarchitectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
The more risk factors (eg history of fracture, advanced age, comorbidities, etc) that are present, the greater the risk of fracture.
Drug Information

Indication: Correction of combined vit D & Ca deficiency in the elderly. Adjunct to treatment of osteoporosis in patie...

Indication: Osteoporosis in postmenopausal women & prevents fractures in men.

Indication: Prevention & treatment of Ca deficiency.

Indication: Postmenopausal osteoporosis. Reduce risk of vertebral & hip fractures.

Indication: Postmenopausal osteoporosis, to reduce the risk of fractures.

Calcium with Vitamin D Plus YSP
calcium carbonate + vitamin D

Indication: Dietary supplement.

Cebion Vitamin C + Calcium Effervescent Tablet
ascorbic acid + calcium carbonate

Indication: Health supplement.

D-Cure
vitamin D

Indication: Prevention & treatment of vit D deficiency. Adjunctive therapy to osteoporosis in patients w/ vit D defici...

1  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 10 Jan 2020

The rates of ovarian cancer in Singapore have more than doubled over the past 40 years, with evidence of variation between the main ethnic groups, a recent study has shown.

Pearl Toh, 19 Feb 2020
Pregnant women with inadequate knowledge on health are more likely to have undesirable maternal outcomes during delivery and adverse outcomes in their offspring than those who were well informed, according to a large cohort study presented at SMFM 2020 Annual Pregnancy Meeting.
01 Sep 2018

Gangliosides and docosahexaenoic acid (DHA) play critical roles in early childhood brain development. 

29 Jan 2020
The risk of adverse pregnancy outcomes appears to be low in women treated with vedolizumab for inflammatory bowel disease, a study has found.